REG - Indivior PLC - Result of General Meeting

IndiviorAnnouncement

30/09/2022 13:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220930:nRSd3949Ba&default-theme=true

RNS Number : 3949B  Indivior PLC  30 September 2022

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR
FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE
RELEVANT LAWS OF SUCH JURISDICTION

Indivior PLC (the 'Company')

Result of General Meeting ('GM')

September 30, 2022

The Company announces the voting results of its GM, held earlier today at the
offices of Freshfields Bruckhaus Deringer LLP, 100 Bishopsgate, London EC2P
2SR.  All resolutions were duly passed by the requisite majority of
shareholders by way of a poll.

Details of each resolution are set out in the shareholder circular including a
Notice of Meeting (the Circular) circulated to shareholders on September 5,
2022.  The voting results, incorporating proxy votes lodged in advance of the
GM, are set out below and will be made available on the Company's website at
http://www.indivior.com/en/investors/shareholder-information
(http://www.indivior.com/en/investors/shareholder-information) .

Capitalised terms used but not defined in this announcement having the meaning
given to them in the Circular.

 

 RESOLUTION                                                                      VOTES        %      VOTES       %     VOTES        % of ISSUED ORDINARY SHARE CAPTIAL VOTED(1)    VOTES

FOR
AGAINST
TOTAL
WITHHELD(2)
 To adopt the new Articles of Association in connection with the Additional US   508,605,977  99.96  178,400     0.04  508,784,377  73.81                                          34,455
 Listing
 To approve the Consolidation of the Company's issued capital in connection      508,516,860  99.95  258,968     0.05  508,775,828  73.81                                          39,004
 with the Additional US Listing pursuant to which every 5 ordinary shares will
 be consolidated into 1 ordinary share

 

Graham Hetherington, Chair, said:

We are pleased with the strong support received from shareholders that will
allow us to move forward with an Additional US Listing of Indivior shares on a
major US stock exchange.  We believe the Additional US Listing will be
beneficial in elevating Indivior's visibility and profile in its largest
market, and will help attract a broader group of biopharma investors.

We anticipate that the Additional US Listing will become effective in the
Spring of 2023 and the Group is diligently working on all requirements to meet
this timing.  Indivior will retain its premium listing on the London Stock
Exchange and expects to continue to be a constituent of the FTSE 250 index.

Next steps and timetable

The expected timetable of principal events as set out in the Circular remains
unchanged and is replicated below. The following dates are indicative only and
are subject to change. If any of the dates set out in the timetable change,
Indivior will give notice of this change by issuing an announcement through a
Regulatory Information Service.

 Event                                                                          Expected time/date
 Consolidation Record Time                                                      6.00 p.m. (London time) on

October 7, 2022
 Admission of New Ordinary Shares to listing on the premium listing segment of  8.00 a.m. (London time) on
 the Official List and to trading on the London Stock Exchange's main market
October 10, 2022
 for listed securities and commencement of dealings in New Ordinary Shares
 Expected date CREST accounts are to be credited with New Ordinary Shares in    October 10, 2022
 uncertificated form
 Expected date for dispatch of definitive certificates for New Ordinary Shares  October 17, 2022
 in certificated form
 Expected date for payment (where applicable) of fractional entitlements for    October 21, 2022
 New Ordinary Shares
 Expected time and date for admission and commencement of dealings in Indivior  By 8.00 a.m. (New York time) on
 Shares on a major US stock exchange
May 31, 2023
 Expected date for issue of Indivior DIs to CREST participant accounts and      On or around May 31, 2023
 crediting of CSN Facility accounts

 

Notes:

 

1.    As at the close of business on September 28, 2022, the total number
of ordinary shares of US$0.10 eligible to be voted at the GM was
688,995,928.   Therefore, the total voting rights in the Company as at that
time was 688,995,928.

 

2.    A vote withheld is not a vote in law and is not counted in the
calculation of the proportion of votes 'for' or 'against' a resolution.

A copy of the special business resolutions will be submitted to the National
Storage Mechanism and will be available to view at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) in due course.

Computershare Investor Services PLC acted as scrutineer of the poll on all
resolutions.

 

Contact:               Kathryn Hudson

Company Secretary
Tel: +44 (0)1753 423940 / cosec@indivior.com

Jason Thompson
Vice President, Investor Relations

Tel: +1-804-402-7123 / jason.thompson@indivior.com

Tulchan Communications
Tel: +44 207-353-4200

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ROMFZGFLZGNGZZM